One of the biggest movers on the local market today has been the Rhinomed Ltd (ASX: RNO) share price.
In afternoon trade the medical technology company's shares are up 10.5% to 21 cents.
What happened?
This morning Rhinomed announced that its sleep and breathing technology Mute, has been added to the annual large set planogram produced by the Hamacher Resource Group in the United States.
The large set planogram is used by up to 10,000 American pharmacies to determine their store layout and what products appear on shelf.
According to the release, Hamacher has advised the company that two Mute SKUs will be included in the Cold and Allergy large set planogram from August.
The company's US-based sales team will be targeting independent pharmacies and wholesalers in the Hamacher network in order to take full advantage of the new planogram.
